HSP90AB1 and cancer: These studies suggest that there is interplay between immune checkpoints and HSP90s and that lymphocytes may upregulate surface HSP90 expression in response to anti-PD-1 immunotherapy, however, further studies are required to understand the role of cancer immunotherapy on the HSP90 expression.